Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolic model for diversity-generating biosynthesis.
Tianero MD, Pierce E, Raghuraman S, Sardar D, McIntosh JA, Heemstra JR, Schonrock Z, Covington BC, Maschek JA, Cox JE, Bachmann BO, Olivera BM, Ruffner DE, Schmidt EW. Tianero MD, et al. Among authors: schonrock z. Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1772-7. doi: 10.1073/pnas.1525438113. Epub 2016 Feb 1. Proc Natl Acad Sci U S A. 2016. PMID: 26831074 Free PMC article.
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.
Braun TP, Coblentz C, Curtiss BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE. Braun TP, et al. Among authors: schonrock z. Proc Natl Acad Sci U S A. 2020 Jun 16;117(24):13670-13679. doi: 10.1073/pnas.1918307117. Epub 2020 May 29. Proc Natl Acad Sci U S A. 2020. PMID: 32471953 Free PMC article.
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Curtiss BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Di Genua C, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Braun TP, et al. Among authors: schonrock z. Nat Commun. 2019 Nov 29;10(1):5455. doi: 10.1038/s41467-019-13364-2. Nat Commun. 2019. PMID: 31784538 Free PMC article.
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia.
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Curtiss BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Di Genua C, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Braun TP, et al. Among authors: schonrock z. Nat Commun. 2022 Jun 16;13(1):3471. doi: 10.1038/s41467-022-30987-0. Nat Commun. 2022. PMID: 35710794 Free PMC article. No abstract available.
[No title available]
[No authors listed] [No authors listed] PMID: 36195644
Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy.
Kalayjian A, Laszlo K, Fassler M, Schonrock Z, Delarose KE, Ly AM, English CD, Cirrincione LR. Kalayjian A, et al. Among authors: schonrock z. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):283-289.e2. doi: 10.1016/j.japh.2023.10.005. Epub 2023 Oct 13. J Am Pharm Assoc (2003). 2024. PMID: 37839699 Free article.
12 results